SenoRx Announces Participation in Upcoming Investor Conferences


ALISO VIEJO, Calif., March 6, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following conferences:


   Cowen and Company 28th Annual Health Care Conference
   The Boston Marriott Copley Place, Boston, MA
   Tuesday, March 18, 2008 - 8:45 a.m. Eastern Time

   Citi 5th Annual Small & Mid-Cap Conference
   Four Seasons Hotel, Las Vegas, NV
   Wednesday, March 19, 2008 - 9:25 a.m. Pacific Time (12:25 p.m. EST)

SenoRx invites investors and those interested to listen to a live webcast of these presentations via the Internet on the Investor Relations section of the company's Web site www.senorx.com. A webcast replay of these presentations will be available approximately one hour after each live presentation and will be archived for approximately 30 days following each webcast.

About SenoRx

SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its flagship EnCor(r) system and Contura(tm) MLB. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 18 products having received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.

The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605



            

Kontaktdaten